News | November 10, 2023
GSK registers 5% revenue growth in Q2 FY24
General Medicine grows 5% and Vaccines 10% led by Shingrix
General Medicine grows 5% and Vaccines 10% led by Shingrix
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
hey were educated about the 7- step hand-washing technique trainings
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
AAT is a substantial socio-economic burden to livestock farmers in Sub-Saharan Africa, affecting and killing millions of cattle every year
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Meningitis still affects more than 2.5 million people globally each year
The company has entered into a three-year Deferred Prosecution Agreement
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
